News · Rare Disease
846 stories
Aug 22, 26Everything Sprouts, LLC Recalls Alfalfa Sprouts Due to Potential E. Coli and Salmonella Risk
Aug 21, 26‘A neuroscience revolution’: The GLP-like race to keep us awake and make billions doing it
Aug 21, 26Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug
Aug 20, 26Ultragenyx bags first gene therapy approval as previously rejected Sanfilippo asset awaits decision